Literature DB >> 1420897

Dimerization kinetics of the IgE-class antibodies by divalent haptens. I. The Fab-hapten interactions.

R Schweitzer-Stenner1, A Licht, I Pecht.   

Abstract

The binding of divalent haptens to IgE-class antibodies leads predominantly to their oligomerization into open and closed dimers. Kinetics of the open dimer formation was investigated by fluorescence titrations of Fab fragments of monoclonal DNP-specific IgE antibodies with divalent haptens having different spacer length (gamma = 14-130 A). Binding was monitored by quenching of intrinsic tryptophan emission of the Fab. Addition of divalent haptens with short spacers (gamma = 14-21 A) to the Fabs at rates larger than a distinct threshold value caused a significant decrease of Fab-binding site occupation in the initial phase of the titration. This finding was interpreted to reflect a nonequilibrium state of hapten-Fab-binding. Such nonequilibrium titrations were analyzed by inserting a kinetic model into a theory of antibody aggregation as presented by Dembo and Golstein (Histamine release due to bivalent penicilloyl haptens. 1978. J. Immunol. 121, 345). Fitting of this model to the fluorescence titrations yielded dissociation rate constants of 7.8 x 10(-3) s-1 and 6 x 10(-3) s-1 for the Fab dimers formed by the flexible divalent haptens N alpha, N epsilon-di(dinitrophenyl)-L-lysine (gamma = 16 A) and bis(N beta-2,4-dinitrophenyl-alanyl)-meso-diamino-succinate (gamma = 21 A). Making the simplifying assumption that a single step binding equilibrium prevails, the corresponding dimer formation rate constants were calculated to be 1.9 x 10(5) M-1 s-1 and 1.1 x 10(4) M-1 s-1, respectively. In contrast, all haptens with spacers longer than 40 A (i.e., bis(N alpha-2,4-dinitrophenyl-tri-D-alanyl)-1,7-diamino-heptane, and di(N epsilon-2,4-dinitrophenyl)-6-aminohexanoate-aspartyl-(prolyl)n-L-l ysyl (n = 24, 27, 33) exhibit a relative fast dimerization rate of the Fab fragments (greater than 7 x 10(6) M-1 s-1). These observations were interpreted as being caused by orientational constraints set by the limited solid angle of the reaction between the macromolecular reactants. Thus, ligands having better access to the binding site would react faster.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420897      PMCID: PMC1262177          DOI: 10.1016/S0006-3495(92)81609-0

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  27 in total

1.  Bivalent hapten-antibody interactions--1. A comparison of water soluble and water insoluble bivalent haptens.

Authors:  R L Wilder; G Green; V N Schumaker
Journal:  Immunochemistry       Date:  1975-01

2.  Some invariant properties of IgE-mediated basophil activation and desensitization.

Authors:  B Goldstein; M Dembo; A K Sobotka; L M Lichtenstein
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody.

Authors:  B Goldstein; R G Posner; D C Torney; J Erickson; D Holowka; B Baird
Journal:  Biophys J       Date:  1989-11       Impact factor: 4.033

4.  Kinetic mapping of the antibody combining site by chemical relaxation spectrometry.

Authors:  D Haselkorn; S Friedman; D Givol; I Pecht
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

5.  IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones.

Authors:  E L Barsumian; C Isersky; M G Petrino; R P Siraganian
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

6.  A common mechanism of hapten binding to immunoglobulins and their heterologous chain recombinants.

Authors:  R Zidovetzki; Y Blatt; C P Glaudemans; B N Manjula; I Pecht
Journal:  Biochemistry       Date:  1980-06-10       Impact factor: 3.162

7.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

Authors:  F T Liu; J W Bohn; E L Ferry; H Yamamoto; C A Molinaro; L A Sherman; N R Klinman; D H Katz
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

8.  Cell surface IgE on human basophil granulocytes.

Authors:  T Ishizaka; K Ishizaka
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

9.  Fluorescence resonance energy transfer on single living cells. Application to binding of monovalent haptens to cell-bound immunoglobulin E.

Authors:  U Kubitscheck; M Kircheis; R Schweitzer-Stenner; W Dreybrodt; T M Jovin; I Pecht
Journal:  Biophys J       Date:  1991-08       Impact factor: 4.033

10.  Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells.

Authors:  E Ortega; R Schweitzer-Stenner; I Pecht
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  4 in total

1.  Ligand-receptor kinetics measured by total internal reflection with fluorescence correlation spectroscopy.

Authors:  Alena M Lieto; Randall C Cush; Nancy L Thompson
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

2.  Modeling multivalent ligand-receptor interactions with steric constraints on configurations of cell-surface receptor aggregates.

Authors:  Michael I Monine; Richard G Posner; Paul B Savage; James R Faeder; William S Hlavacek
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

3.  A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.

Authors:  Başar Bilgiçer; Samuel W Thomas; Bryan F Shaw; George K Kaufman; Vijay M Krishnamurthy; Lara A Estroff; Jerry Yang; George M Whitesides
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

Review 4.  Critical parameters for design and development of multivalent nanoconstructs: recent trends.

Authors:  Avijit Kumar Bakshi; Tanweer Haider; Rahul Tiwari; Vandana Soni
Journal:  Drug Deliv Transl Res       Date:  2022-01-11       Impact factor: 5.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.